FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Fate Therapeutics
Fate Therapeutics
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Roswell Park Cancer Institute
Rutgers, The State University of New Jersey